New Research: Expression of TRX1 optimizes the antitumor functions of human CAR T cells and confers resistance to a pro-oxidative tumor microenvironment: Use of chimeric antigen receptor (CAR) T cells to treat B cell lymphoma and leukemia has… https://t.co/ovECUbp169 #immunology
https://t.co/CmnrvOGUXK
Our latest review is out.
In our review article, we highlighted the components of immunosuppressive tumor microenvironment and potential strategies to consider for more efficient immunotherapy of solid tumors
New Research: Redox Regulation of the Actin Cytoskeleton in Cell Migration and Adhesion: On the Way to a Spatiotemporal View: The actin cytoskeleton of eukaryotic cells is a dynamic, fibrous network that is regulated by the concerted action… https://t.co/mq9qXvSBqp #celldevbio
Check our latest paper on CD95 activation published @CellReports- a matter of decision: survive together or die alone! Congrats @gulcegulculer and everyone involved! #cancerresearch@DKFZ https://t.co/Ow91YAlznp
Activation of #CD95, a receptor found on all #cancer cells, triggers programmed cell death – or stimulates cancer cell growth. The impact of CD95 activation depends on whether there are isolated cancer cells or three-dimensional structures. https://t.co/sY46aUfV9N #CancerResearch
Take a look at our latest publication on reversibility of stem cell decisions via post-transcriptional regulation https://t.co/BsooEEwefs #neuroscience#stemcells